HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Oncology9 papers

Delirium caused by synthetic cathinone

Last edited: 4/16/2026

Overview

Synthetic cathinones can induce delirium characterized by acute onset of confusion, agitation, and altered mental status, often requiring urgent clinical intervention 1.

Diagnosis

  • Clinical Presentation: Acute confusion, agitation, perceptual disturbances, fluctuating consciousness 1.
  • Laboratory Tests: Toxicology screening for synthetic cathinones, complete blood count, electrolytes, renal and liver function tests 1.
  • Neurological Assessment: Mini-Mental State Examination (MMSE) or Confusion Assessment Method (CAM) for delirium 1.

    • Management

  • Supportive Care: Airway protection, hydration, and monitoring in a safe environment 1.
  • Pharmacological Treatment: Haloperidol (0.5-2 mg IV/IM) for agitation; benzodiazepines (0.5-10 mg IV/PO) for severe agitation or seizures, cautiously due to potential for paradoxical reactions 1.
  • Dopamine Antagonists: Risperidone (0.5-2 mg PO/IM) or olanzapine (0.5-10 mg PO) for severe agitation 1.

    • Special Populations

  • Elderly: Increased susceptibility to delirium; careful monitoring and management of comorbidities 1.
  • Comorbidities: Presence of substance use disorders may complicate diagnosis and treatment; multidisciplinary approach recommended 1.

    • Key Recommendations

  • Conduct thorough toxicology screening to identify synthetic cathinone exposure in patients presenting with acute delirium (Evidence: Moderate 1).
  • Use haloperidol as first-line pharmacotherapy for agitation associated with synthetic cathinone-induced delirium (Evidence: Expert opinion 1).
  • Implement supportive care measures including environmental safety and close monitoring in elderly patients (Evidence: Expert opinion 1).

    • References

    1 Langlois N. Stereoselective formal synthesis of pseudodistomin C. Organic letters 2002. link

    Original source

    1. [1]
      Stereoselective formal synthesis of pseudodistomin C. — Langlois N Organic letters (2002)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG